Time Speaker/Session Introduction
08:00 - 09:00 Continental Breakfast
08:45 - 9:00 Welcome to the Symposium - Opening Remarks: Raj Rajur (CreaGen Inc., Chair, Medicinal Chemistry NESACS) and Mark Ashwell (Nimbus Therapeutics)
Morning Session Chair: Adrian Hobson, Abbvie
09:00 - 09:50 M. Christina White, University of Illinois
Title: Late-Stage C—H Functionalization for Diversification
Introduced by Andrew Scholte (Sanofi)
09:50 - 10:40 Matthew LaMarche, Novartis
Title: Allosteric Inhibition of SHP2 Phosphatase
Introduced by Lisa Marcaurelle (GSK)
10:40 - 11:10 Networking break with refreshments & food
11:10 - 12:00 Jin-Quan Yu, Scripps Research Institute
Title: Molecular Editing through Enantioselective and Remote C–H Activation
Introduced by Blaise Lippa (Morphic)
12:00 – 14:00 Lunch Break - Sandwich Buffet
Afternoon Session Chair: Brian Aquila (Alkermes)
14:00 - 14:50 Nate Fuller, Alkermes
Title: To Be Announced
Introduced by Brian Aquila (Alkermes)
14:50 - 15:40 Rebecca T. Ruck, Merck
Title: Enabling Technologies for the Development of Best Process
Introduced by Scott Edmondson (AstraZeneca)
15:40 - 16:10 Networking break with refreshments & food
16:10 - 17:00
Keynote Presentation: Prof. Robert Grubbs, Nobel Laureate, California Institute of Technology
Title: To Be Announced
Introduced by Brian Aquila
17:00 - 18:00 Closing remarks Dan Elbaum (QurAlis)
Social Networking with beer, wine & food - NESACS